Current position:Home >Product >
2-[(4-Bromophenyl)oxymethyl]-4-(4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)butyric acid
2-[(4-Bromophenyl)oxymethyl]-4-(4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)butyric acid(253441-95-1)
- Name: 2-[(4-Bromophenyl)oxymethyl]-4-(4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)butyric acid
- Synonyms:
- Molecular Formula:
- Molecular Weight:418.247
- CAS Registry Number:253441-95-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 405207-61-6/1-(2-methoxyethyl)-3-(2-{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)-1,3-dihydro-2H-benzimidazol-2-one
- 330550-66-8/2-[3-Chloro-4-(3-chloro-pyrrolidin-1-yl)-phenylamino]-8-cyclopentyl-8H-pteridin-7-one
- 466664-65-3/3-Methyl-1-{1-[5-methyl-2-(4-trifluoromethyl-phenyl)-1H-imidazol-4-ylmethyl]-piperidin-4-yl}-1-propyl-urea
- 441064-94-4/2-(3-cyclohexyl-5,6-dihydro-8H-imidazo[1,5-a]pyrazin-7-yl)-6,7-dimethoxy-1H-quinazolin-4-one
- 503166-92-5/(3R,4R)-4-({4-[(2-cyclopropyl-1H-benzimidazol-1-yl)methyl]benzoyl}amino)-N-hydroxytetrahydro-2H-pyran-3-carboxamide
- 352327-36-7/3-tert-Butyl-1-{2-[4-(cis-3,5-dimethyl-piperazin-1-yl)-phenylamino]-pyrido[2,3-d]pyrimidin-7-yl}-1-ethyl-urea
- 500107-79-9/N-{3-[4-(1,2-diphenyl-but-1-enyl)-phenyl]-acryloyl}-3-trifluoromethyl-benzenesulfonamide
- 478406-73-4/N'-[4-cyano-2,3-dihydroxy-1-(4-hydroxybenzyl)butyl]-5-methyl-N,N-dipropylisophthalamide
- 344780-67-2/(R)-N-[5-[2-[2-(7-hydroxy-9H-carbazol-2-yloxy)ethylamino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide
- 479632-37-6/2-(1-Bromo-6-{[(1-phenyl-5-propyl-1H-pyrazole-4-carbonyl)-amino]-methyl}-naphthalen-2-yloxy)-3-phenyl-propionic acid
- 218594-17-3/(2R)-1-(3,5-Dichlorobenzoyl)-2-[(1H-indol-3-yl)methyl]-piperazine hydrochloride
- 388097-63-0/(3R,4R)-4-[3-(3-acetyl-phenyl)-ureido]-3-[(S)-3-(4-fluoro-benzyl)-piperidin-1-ylmethyl]-piperidine-1-carboxylic acid methyl ester
- 473475-85-3/10-[(6-Chloro-3-methoxy-2'-methyl-[1,1'-biphenyl]-4-yl)carbonyl]-N-[2-(2-pyridinyl)ethyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide
- 352328-75-7/4-{4-[7-(3-Cyclohexyl-3-methyl-ureido)-pyrido[2,3-d]pyrimidin-2-ylamino]-phenyl}-piperazine-1-carboxylic acid tert-butyl ester
- 428814-98-6/3-{4-[1-(4-cyclohexylcyclohexyl)-3-(3-cyanophenyl)ureidomethyl]benzoylamino}propionic acid
- 428815-12-7/3-{4-[1-(4-cyclohex-1-enylphenyl)-3-(4,6-dichlorobenzothiazol-2-yl)ureidomethyl]benzoylamino}propionic acid
- 347183-24-8/(1S,3R)-1-(9-chloro-3-methyl-4-oxo-5H-isoxazolo[4,3-c]quinolin-5-yl)-3-[((2R)-2-amino-2-phenylacetyl)-amino]cyclohexane hydrochloride
- 254910-88-8/4-(4-phenyl-2-oxazolyl]benzoic acid
- 298697-29-7/N-{2-[4-(3,4-Dichlorophenoxy)-1-piperidinyl]ethyl}-2-pyrimidinamine
- 253441-95-1/2-[(4-Bromophenyl)oxymethyl]-4-(4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)butyric acid
- 320407-51-0/3-(trans-4-Formamidocyclohexyl)-6-trifluoromethyl-2,3-dihydro-1H-imidazo[4,5-b]pyridin-2-one
- 233275-68-8/7-cyclobutyl-3-(2-fluorophenyl)-6-(1-methyl-1H-1,2,4-triazol-3-ylmethoxy)-1,2,4-triazolo[4,3-b]pyridazine
- 1314007-26-5/C18H16N2O2
- 1409989-74-7/4-(4-methyl-piperazin-1-yl)-N-{6-[2-(3-trifluoromethyl-benzyloxy)-ethoxy]-1H-indazol-3-yl}-benzamide
- 1255392-37-0/3-[(2S,8S,9S)-11-[(2R)-1-hydroxypropan-2-yl]-2,9-dimethyl-8-{[N-methyl(4-fluorobenzene)sulfonamido]methyl}-12-oxo-2,3,4,5,6,8,9,10,11,12-decahydro-1,7,11-benzodioxazacyclotetradecin-14-yl]-1-phenylurea
- 1255400-56-6/3-[(2R,8R,9R)-11-[(2S)-1-hydroxypropan-2-yl]-2,9-dimethyl-8-{[N-methyl(4-fluorobenzene)sulfonamido]methyl}-12-oxo-2,3,4,5,6,8,9,10,11,12-decahydro-1,7,11-benzodioxazacyclotetradecin-14-yl]-1-phenylurea
- 1415256-92-6/1-((2'-(tert-butoxycarbonyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-indole-5-carboxylic acid
- 1414554-59-8/1-((3S,4R)-4-(3-fluorophenyl)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-3-(2-phenyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-yl)urea
- 1415091-85-8/N-butyl-4-chloro-N-(4-methoxyphenyl)-5-methyl-1-(4-(naphthalen-2-ylsulfonylcarbamoyl)-2-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-1H-pyrazole-3-carboxamide
- 1332497-74-1/C35H30F4N2O3SSe